226 related articles for article (PubMed ID: 15628756)
1. [Chemotherapy for hepatocellular carcinoma].
Okusaka T; Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756
[TBL] [Abstract][Full Text] [Related]
2. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
[TBL] [Abstract][Full Text] [Related]
3. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
[TBL] [Abstract][Full Text] [Related]
4. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
[TBL] [Abstract][Full Text] [Related]
5. [The chemotherapy for hepatocellular carcinoma].
Nagano H; Sakon M; Monden M
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1895-900. PubMed ID: 14650956
[TBL] [Abstract][Full Text] [Related]
6. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC
J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
Ikeda M; Okusaka T; Ueno H; Takezako Y; Morizane C
Cancer; 2005 Feb; 103(4):756-62. PubMed ID: 15637692
[TBL] [Abstract][Full Text] [Related]
9. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma.
Woo HY; Bae SH; Park JY; Han KH; Chun HJ; Choi BG; Im HU; Choi JY; Yoon SK; Cheong JY; Cho SW; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
Cancer Chemother Pharmacol; 2010 Jan; 65(2):373-82. PubMed ID: 19763572
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma (HCC): the long-term response to tamoxifen. A clinical case report and review of the literature].
Recchia F; Passalacqua G; Rodorigo C; Belli L; Morgante A; Rabitti G
Minerva Med; 1989 Dec; 80(12):1363-6. PubMed ID: 2560153
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma].
Zhang ZH; Ma LW; Song SB; Xiu DR; Wang JJ; Yang XX; Jia YM
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):45-7. PubMed ID: 15771799
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
Ikeda M; Okusaka T; Ueno H; Morizane C; Kojima Y; Iwasa S; Hagihara A
Jpn J Clin Oncol; 2008 Oct; 38(10):675-82. PubMed ID: 18716041
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
17. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic arterial infusion chemotherapy using totally implantable port system].
Takayasu Y; Yamamoto S; Ikeda J
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of continuous arterial infusion chemotherapy for post operative multiple recurrence and residual hepatocellular carcinoma].
Yanagi I; Koga A; Okuda K; Nishio T; Shibata J; Aso K; Matuo H; Nagashima J; So H; Nakayama T
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1419-21. PubMed ID: 8854768
[TBL] [Abstract][Full Text] [Related]
20. [Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy].
Anami Y; Oguma S; Matsuda Y; Yamaki T; Sazawa Y; Komiya H; Izai J; Ota T
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1977-80. PubMed ID: 16282739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]